CVE-2026-123218
CRITICAL CISA KEV
ACT NOW
Priority: 0.05
BB Relevance:
80/100
Published: 2026-11-07
Modified: 2026-11-10
First seen: 2026-11-07
Status: active
Attack Surface
Network
Low Complexity
No Auth
No Interaction
Conf. Impact
Integ. Impact
CVSS Vector Breakdown
AV:
Network
AC:
Low
PR:
None
UI:
None
S:
Unchanged
C:
High
I:
High
A:
High
Description
IBM Aspera Faspex contains an incorrect authorization vulnerability that could allow an authenticated user to craft a specific message to bypass authorization, causing privilege escalations.
CISA Known Exploited Vulnerability
Vendor / Product
IBM — Aspera Faspex
Date Added
2026-11-09
Remediation Due
2026-11-12
https://www.ibm.com/support/pages/node/7295921 ; BOD 26-04: https://www.cisa.gov/news-events/directives/bod-26-04-prioritizing-security-updates-based-risk ; Forensics Triage Requirements: https://www.cisa.gov/news-events/directives/bod-26-04-implementation-guidance-prioritizing-security-updates-based-risk ; https://nvd.nist.gov/vuln/detail/CVE-2026-123218
Weakness Classification (1)
Affected Software (6)
| Vendor | Product | Version |
|---|---|---|
| IBM | Aspera Faspex | 5.0.0 |
| IBM | Aspera Faspex | 5.0.0 |
| IBM | Aspera Faspex | 5.0.0 |
| IBM | Aspera Faspex | 5.0.0 |
| IBM | Aspera Faspex | 5.0.0 |
| ibm | aspera_faspex | 5.0.0 – 5.0.19.1 |
References & Advisories (2)
vendor-advisory
patch